Product Information
GLATIRAMER 40 MG/ML SYRINGE is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $95.4165 per ML under NDC 00378696112. Its NADAC has been published 349 times since Oct 23, 2019.
Strength
40 mg/mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378696112
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
GLATIRAMER ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA206936On Market Since
10/4/2017
Price Statistics
The NADAC for GLATIRAMER 40 MG/ML SYRINGE has been published 349 times since Oct 23, 2019, and over the history we have for it it has declined 40.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $95.4165 per ML |
|---|---|
| All-time high | $159.2183 (Nov 13, 2019) |
| All-time low | $93.6923 (Feb 19, 2025) |
| 52-week high | $109.5166 |
| 52-week low | $95.4165 |
| Median price | $125.4714 |
| Average price | $122.1196 |
| Largest weekly change | -14.8% (Nov 20, 2024) |
| Weeks tracked | 349 |
| Tracking since | Oct 23, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Glatiramer market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of GLATIRAMER 40 MG/ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for GLATIRAMER 40 MG/ML SYRINGE, manufactured by Mylan Pharmaceuticals Inc., is $95.4165 per ML (NDC 00378696112), effective Jun 24, 2026.
How has the price of GLATIRAMER 40 MG/ML SYRINGE changed over time?
Over the history we have for it, the NADAC for GLATIRAMER 40 MG/ML SYRINGE has declined 40.1%. It has been tracked across 349 weekly CMS publications since Oct 23, 2019.
What are the highest and lowest recorded NADAC prices for GLATIRAMER 40 MG/ML SYRINGE?
Since Oct 23, 2019, the NADAC for GLATIRAMER 40 MG/ML SYRINGE has ranged from a low of $93.6923 (Feb 19, 2025) to a high of $159.2183 (Nov 13, 2019), with a median of $125.4714 per ML.
Are there cheaper alternatives to GLATIRAMER 40 MG/ML SYRINGE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of GLATIRAMER 40 MG/ML SYRINGE, so no direct lower-cost alternative is listed.
Who manufactures GLATIRAMER 40 MG/ML SYRINGE?
GLATIRAMER 40 MG/ML SYRINGE (NDC 00378696112) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification